Literature DB >> 32537584

Use of a Hepatitis C Screening Order Set to Improve Screening Rates and Measure Intervention Effectiveness.

Victoria L Prince1, Sean McNamara1, Ken Gondor1, Susan Pohl1, Osman Sanyer1, Kara A Frame1.   

Abstract

INTRODUCTION: Hepatitis C virus (HCV) infection leads to significant morbidity and mortality. Rates of HCV infection are greatest in patients born from 1945 to 1965, so the Centers for Disease Control recommends a one-time screening in this cohort. Previous interventions utilizing the electronic medical record (EMR) capabilities at two University of Utah Family Medicine clinics have increased screening rates significantly, but further improvement is possible.
METHODS: A family medicine resident-led continuous quality improvement (CQI) team used the Model for Improvement methods popularized by the Institute for Healthcare Improvement to create a team-based intervention with the goal of improving HCV screening in a family medicine faculty and resident clinic. An order set was created and a protocol developed that allowed medical assistants or clinic phlebotomists to order the appropriate HCV screening lab if this had not yet been done by the primary care provider. Data were extracted from the EMR that showed changes in total and monthly screening rates as well as the frequency of order set use.
RESULTS: Monthly screening rates at the Madsen Family Medicine Clinic (Salt Lake City, UT) increased from approximately 40% to greater than 50% in the 5-month intervention period. The order set was used 19 times during this period which accounted for 18.8% of new screens.
CONCLUSIONS: Creating an order set that allows medical assistants to order the HCV screening lab increased HCV screening rates in our clinic. Because order set utilization data can be extracted from the EMR, this intervention provided a process measure that can differentiate the effect of this intervention from the effects of other interventions previously undertaken in the clinic.
© 2019 by the Society of Teachers of Family Medicine.

Entities:  

Year:  2019        PMID: 32537584      PMCID: PMC7205095          DOI: 10.22454/PRiMER.2019.282710

Source DB:  PubMed          Journal:  PRiMER        ISSN: 2575-7873


  6 in total

1.  Hospital-Based Hepatitis C Screening of Baby Boomers in a Majority Hispanic South Texas Cohort: Successes and Barriers to Implementation.

Authors:  Barbara S Taylor; Joshua T Hanson; Poornachand Veerapaneni; Roberto Villarreal; Kristin Fiebelkorn; Barbara J Turner
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

2.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

3.  Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.

Authors:  Joshua A Barocas; Jianing Wang; Laura F White; Abriana Tasillo; Joshua A Salomon; Kenneth A Freedberg; Benjamin P Linas
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 9.048

4.  Hepatitis C: improving the quality of screening in a community hospital by implementing an electronic medical record intervention.

Authors:  Vahe Shahnazarian; Eric Karu; Parag Mehta
Journal:  BMJ Qual Improv Rep       Date:  2015-05-20

5.  Electronic medical record alert improves HCV testing for baby boomers in primary care setting: adults born during 1945-1965.

Authors:  Eyad Al-Hihi; Caylin Shankweiler; David Stricklen; Cheryl Gibson; Winston Dunn
Journal:  BMJ Open Qual       Date:  2017-10-21

6.  "Tweak Your Order Set!" Implementation of Modified Laboratory Order Set Improves Hepatitis C Virus Screening Rates in People Living With Human Immunodeficiency Virus.

Authors:  Alysse G Wurcel; Daniel D Chen; Kenneth K H Chui; Tamsin A Knox
Journal:  Open Forum Infect Dis       Date:  2017-05-16       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.